found that the epigenetic modulators decitabine and chidamide were able to upregulate CD70 expression in AML cells, which in turn enhanced the targeted killing effect of nanobody‐based nb70CAR‐T cells. The gene discussed is CD70; the disease is acute myeloid leukemia.